Foundation Medicine Reaches 100 Approved Companion Diagnostic Indications
The precision medicine company now has 57 approvals in the US and 43 in Japan for its FoundationOne CDx and FoundationOne Liquid CDx tests.
Read More
Search Results for: lung cancer
Natera Acquires Foresight Diagnostics in $450 Million Deal
Transaction expands Natera’s solid tumor MRD capabilities and adds ultrasensitive phased variant technology with detection below 0.1 parts per million.
Read More
Blood Test May Match CT for Early Lung Cancer Detection
The Mercy Halo test demonstrates performance similar to low-dose CT screening with the potential to reach underscreened populations.
Read More
New Data Shows How Plasma Detect Assay May Support Cancer Treatment Decisions
Research demonstrates the MRD assay’s utility in tracking disease progression and predicting treatment outcomes.
Read More
Lunit, Labcorp Partner on AI-Powered Digital Pathology Research
The collaboration combines Labcorp’s clinical expertise with Lunit’s AI algorithms to analyze tumor microenvironments and enhance biomarker discovery.
Read More